Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



GRAVITAS-309: Itacitinib or Placebo in Combination With Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease

Hematologic

The purpose of this study is to assess the efficacy and safety of itacitinib in combination with corticosteroids as first-line treatment for moderate or severe chronic graft-versus-host disease (cGVHD).
Hematologic
III
Jagasia, Madan
NCT03584516
VICCCTT1910

A Phase 1 / 2 Study to Evaluate SNDX- 6352 in Subjects With Active cGVHD

Multiple Cancer Types

This is a Phase 1 / 2, Open-label, Dose Escalation study to investigate SNDX-6352 in subjects with active cGVHD.
Hematologic, Phase I
I
Jagasia, Madan
NCT03604692
VICCCTTP18109

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: